Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-058916

Director sold 3,994 shares at an average $34.55 ($138,000)

  • Director acquired 2,057 shares (option exercise)
  • Director gave up 120 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2022-11-23 Sale −2,057 $34.33 $70,610 23,573 D: show line 1 in the form
PATOU GARY Director 2022-11-25 Option exercise +2,057 $2.68 $5,513 25,630 D: show line 2 in the form
PATOU GARY Director 2022-11-25 Shares withheld for taxes −120 $34.37 $4,124 25,510 D: show line 3 in the form
PATOU GARY Director 2022-11-25 Sale −1,937 $34.79 $67,390 23,573 D: show line 4 in the form
Open-market sales · 3,994 sh · avg $34.55 · $138,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2022-11-25 Option exercise · Stock Option (Right to Buy) −2,057 0 D: show line 5 in the form
Loading xslF345X03/doc4.xml…